Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma

被引：0
|
作者：
Kröger, N
Shimoni, A
Zagrivnaja, M
Ayuk, F
Lioznov, M
Schieder, H
Renges, H
Fehse, B
Zabelina, T
Nagler, A
Zander, A
机构：
[1] Zander Univ, Hosp Hamburg, Hamburg, Germany
[2] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
下载
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [31] Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
    Bethge, WA
    Hegenbart, U
    Stuart, MJ
    Storer, BE
    Maris, MB
    Flowers, MED
    Maloney, DG
    Chauncey, T
    Bruno, B
    Agura, E
    Forman, SJ
    Blume, KG
    Niederwieser, D
    Storb, R
    Sandmaier, BM
    BLOOD, 2004, 103 (03) : 790 - 795
  • [32] Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
    Groeger, Maximilian
    Gagelmann, Nico
    Wolschke, Christine
    von Pein, Ute-Marie
    Klyuchnikov, Evgeny
    Christopeit, Max
    Zander, Axel
    Ayuk, Francis
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (07) : 1399 - 1405
  • [33] Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
    Ballester, OF
    Fang, T
    Raptis, A
    Ballester, G
    Wilcox, P
    Hiemenz, J
    Tan, B
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 419 - 423
  • [34] Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
    O F Ballester
    T Fang
    A Raptis
    G Ballester
    P Wilcox
    J Hiemenz
    B Tan
    Bone Marrow Transplantation, 2004, 34 : 419 - 423
  • [35] Maintenance with low-dose thalidomide after autoSCT in multiple myeloma
    Pezzullo, L
    Rocco, S
    Finizio, O
    Bene, L
    Casale, B
    De Rosa, C
    Mettivier, V
    BONE MARROW TRANSPLANTATION, 2005, 35 : S387 - S387
  • [36] Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma
    van de Donk, NWCJ
    Kröger, N
    Hegenbart, U
    Corradini, P
    San Miguel, JF
    Goldschmidt, H
    Perez-Simon, JA
    Zijlmans, M
    Raymakers, RA
    Montefusco, V
    Ayuk, FA
    van Oers, MHJ
    Nagler, A
    Verdonck, LF
    Lokhorst, HM
    BLOOD, 2006, 107 (08) : 3415 - 3416
  • [37] Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
    Roddie, Claire
    Peggs, Karl S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (04) : 473 - 487
  • [38] Induction of molecular remission by donor lymphocyte infusions in patients with multiple myeloma and residual disease after dose-reduced conditioning and allogeneic stem cell transplantation
    Zagrivnaja, M
    Fehse, B
    Zander, A
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2004, 33 : S326 - S326
  • [39] Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state AML after allogeneic stem cell transplantation
    Hartwig, M.
    Weigel, S.
    Bernig, T.
    Bader, P.
    Doelken, R.
    Beck, J.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2007, 24 (02) : 137 - 140
  • [40] Adoptive immunotherapy with tumor-derived donor lymphocytes after allogeneic hematopoietic stem cell transplantation
    Hardy, NM
    Fallowes, V
    Mariotti, J
    Carter, C
    June, C
    Levine, B
    Hakim, F
    Vanderheide, R
    Gress, R
    Read, EJ
    Fowler, D
    Bishop, MR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 44 - 44
12345